Article
Disrupting the Feed-Forward Cycle of RyR1 Ca <sup>2+</sup> Leak and Oxidative Stress Mitigates Doxorubicin-Induced Skeletal Myopathy
2025-11-13
Abstract excerpt
Doxorubicin (DOX), a highly effective and widely used chemotherapeutic agent used to treat various types of cancer. Unfortunately, DOX also has some undesirable and off-target effects, particularly debilitating muscle weakness and fatigue. The mechanism behind this DOX-induced skeletal myotoxicity (DISM) remains unclear. Here, we show that acute DOX exposure, at clinically relevant concentrations, impairs isometri...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 49a525cd-c76e-5351-8589-cf7fe52faf0d
- DOI
- 10.1101/2025.11.12.688073
